SUTRO BIOPHARMA, INC. — All Filings
593 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
3/A
4
4/A
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
POS AM
POS EX
POSASR
PRE 14A
REGDEX
REGDEX/A
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-3MEF
S-8
SC 13D
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G | — | 0001104659-25-064161 | Jun 30, 2025 | — |
| 8-K | 8-K | 0000950170-25-089978 | Jun 25, 2025 | Jun 20, 2025 |
| 4 | — | 0001415889-25-016471 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-016463 | Jun 10, 2025 | Jun 6, 2025 |
| 8-K | 8-K | 0001193125-25-138481 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-016464 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-016466 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-016467 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-016469 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-016470 | Jun 10, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-016468 | Jun 10, 2025 | Jun 6, 2025 |
| 8-K | 8-K | 0001193125-25-133268 | Jun 2, 2025 | — |
| 3 | — | 0001415889-25-015141 | Jun 2, 2025 | — |
| 4 | — | 0001415889-25-015142 | Jun 2, 2025 | — |
| S-8 | S-8 | 0000950170-25-079768 | May 30, 2025 | — |
| 4 | — | 0001415889-25-013618 | May 19, 2025 | May 15, 2025 |
| SCHEDULE 13G | — | 0001085146-25-003248 | May 15, 2025 | — |
| 8-K | 8-K | 0000950170-25-067061 | May 8, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-067072 | May 8, 2025 | Mar 31, 2025 |
| 4 | — | 0001415889-25-011996 | May 5, 2025 | May 1, 2025 |
| 4 | — | 0001415889-25-011997 | May 5, 2025 | May 1, 2025 |
| 4 | — | 0001415889-25-011998 | May 5, 2025 | May 1, 2025 |
| DEFA14A | DEFA14A | 0000950170-25-058787 | Apr 25, 2025 | — |
| ARS | ARS | 0001140361-25-015788 | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0000950170-25-058774 | Apr 25, 2025 | Jun 6, 2025 |
| SCHEDULE 13G/A | — | 0001576419-25-000809 | Apr 17, 2025 | — |
| 4 | — | 0001415889-25-010683 | Apr 15, 2025 | Apr 11, 2025 |
| 8-K | 8-K | 0000950170-25-053733 | Apr 14, 2025 | Apr 10, 2025 |
| PRE 14A | PRE 14A | 0000950170-25-053739 | Apr 14, 2025 | Jun 6, 2025 |
| 4 | — | 0001415889-25-010384 | Apr 8, 2025 | Apr 4, 2025 |
| 4 | — | 0001415889-25-010382 | Apr 8, 2025 | Apr 4, 2025 |
| 4 | — | 0001415889-25-010385 | Apr 8, 2025 | Apr 4, 2025 |
| 3 | — | 0001415889-25-010380 | Apr 8, 2025 | Apr 4, 2025 |
| 4 | — | 0001415889-25-010381 | Apr 8, 2025 | Apr 4, 2025 |
| 4 | — | 0001415889-25-010383 | Apr 8, 2025 | Apr 4, 2025 |
| SCHEDULE 13G | — | 0001415889-25-010207 | Apr 4, 2025 | — |
| 8-K | 8-K | 0000950170-25-038879 | Mar 13, 2025 | — |
| 10-K | 10-K | 0000950170-25-038884 | Mar 13, 2025 | Dec 31, 2024 |
| 4 | — | 0001415889-25-007405 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | — | 0001415889-25-007398 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | — | 0001415889-25-007393 | Mar 7, 2025 | Mar 5, 2025 |
| 4 | — | 0001415889-25-007182 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | — | 0001415889-25-007183 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | — | 0001415889-25-007184 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | — | 0001415889-25-007185 | Mar 6, 2025 | Mar 4, 2025 |
| 4 | — | 0001415889-25-006655 | Mar 4, 2025 | Feb 28, 2025 |
| 4 | — | 0001415889-25-006656 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001415889-25-006690 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001415889-25-006696 | Mar 4, 2025 | Mar 1, 2025 |
| 4 | — | 0001415889-25-006709 | Mar 4, 2025 | Mar 1, 2025 |